Financhill
Back

Evolus Quote, Financials, Valuation and Earnings

Evolus Price Quote

$11.50
-0.07 (-0.61%)
(Updated: April 19, 2024 at 6:55 PM ET)

Evolus Key Stats

Sell
22
Evolus (EOLS) is a Sell

Day range:
$11.26 - $11.69
52-week range:
$7.07 - $15.43
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.26
P/B ratio:
0%

Volume:
283.1K
Avg. volume:
641.3K
1-year change:
41.79%
Market cap:
$711.5M
Revenue:
$202.1M
EPS:
$-1.08

How Much Does Evolus Make?

  • How Much Are Evolus's Sales Annually?
    EOLS Revenues are $202.1M
  • How Much Profit Does Evolus's Make A Year?
    EOLS net income is -$61.7M

Is Evolus Growing As A Company?

  • What Is Evolus's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.4%
  • What Is Evolus's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Evolus Stock Price Performance

  • Did Evolus Stock Go Up Last Month?
    Evolus share price went down by -17.36% last month
  • Did EOLS's Share Price Rise Over The Last Year?
    EOLS share price rose by 41.79% over the past 1 year

What Is Evolus 52-Week High & Low?

  • What Is Evolus’s 52-Week High Share Price?
    Evolus has traded as high as $15.43 over the past 52 weeks
  • What Is Evolus’s 52-Week Low Share Price?
    Evolus has traded as low as $7.07 over the past 52 weeks

Evolus Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Evolus?

  • How Much Debt Does Evolus Have?
    Total long term debt quarterly is $120.4M
  • How Much Cash Does Evolus Have?
    Cash and short term investments quarterly total is $62.8M
  • What Is Evolus’s Book Value Per Share?
    Book value per share is -0.36

Is Evolus Cash Flow Positive?

  • What Is EOLS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$34M
  • What Is Evolus’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $44.6M
  • What Is Evolus’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.6M

Evolus Return On Invested Capital

  • Is Management Doing A Good Job?
    EOLS return on invested capital is -71.29%
  • What Is Evolus Return On Assets?
    ROA measures how assets are converting to revenues and is -35.69%
  • What Is EOLS Return On Equity?
    ROE is a measure of profitability and is 0%

Evolus Earnings Date & Stock Price

  • What Is Evolus's Stock Price Today?
    A single share of EOLS can be purchased today for 11.57
  • What Is Evolus’s Stock Symbol?
    Evolus trades on the nasdaq under the ticker symbol: EOLS
  • When Is Evolus’s Next Earnings Date?
    The next quarterly earnings date for Evolus is scheduled on May 9, 2024
  • When Is EOLS's next ex-dividend date?
    Evolus's next ex-dividend date is April 20, 2024
  • How To Buy Evolus Stock?
    You can buy Evolus shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Evolus Competitors

  • Who Are Evolus's Competitors?
    Below is a list of companies who compete with Evolus or are related in some way:
    • Asensus Surgical Inc (ASXC)
    • Perspective Therapeutics Inc (CATX)
    • Electromed Inc (ELMD)
    • Myomo Inc (MYO)
    • Xtant Medical Holdings Inc (XTNT)

Evolus Dividend Yield

Data Unavailable

Evolus Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -109%
Revenue: 39.76% -0.09%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 22.29
Upside from Last Price: 92.62%

Major Shareholders

  • How many EOLS shares are owned by institutional investors?
    66.3M EOLS shares are owned by institutional investors
  • How many EOLS shares are owned by insiders?
    2.4M EOLS shares are owned by insiders